Cite
Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.
MLA
Magnusson, Peter, et al. “Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.” Pacing & Clinical Electrophysiology, vol. 39, no. 3, Mar. 2016, pp. 291–301. EBSCOhost, https://doi.org/10.1111/pace.12801.
APA
Magnusson, P., Gadler, F., Liv, P., & Mörner, S. (2016). Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy. Pacing & Clinical Electrophysiology, 39(3), 291–301. https://doi.org/10.1111/pace.12801
Chicago
Magnusson, Peter, Fredrik Gadler, Per Liv, and Stellan Mörner. 2016. “Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.” Pacing & Clinical Electrophysiology 39 (3): 291–301. doi:10.1111/pace.12801.